67 results
Page 4 of 4
8-K
EX-99.1
xrnk krii8lzv711d
11 May 20
Sutro Biopharma Reports First Quarter 2020 Financial Results
4:27pm
424B5
8ujxtdf oz872e8sfu
11 May 20
Prospectus supplement for primary offering
4:12pm
8-K
n2tpovll 8bmp
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
8-K
EX-99.2
5c0yn78f0v8q1y46y9
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am
8-K
EX-99.1
7k02fc4fr
27 Apr 20
Sutro Biopharma Announces Encouraging Interim Phase 1 Clinical Data for a Dose Escalation Study of STRO-002 Antibody-Drug Conjugate in Ovarian Cancer
8:00am